02.04.2019 – 15:29
Charité and OPTIMA are developing a production machine for cell and gene therapeutics
- Press release OPTIMA pharma started a cooperation with Charité_Tages- und Wirtschaftspresse_Engl.pdf
PDF - 719 kB
Optima Pharma and Charité - Universitätsmedizin Berlin are developing a concept for the automated production and filling of cell and gene therapeutics. These new types of medications are considered a promising new therapy opportunity for incurable cancer and metabolic diseases. They also pave the way for personalized medication. These medications depend on the patient's cells. They are still produced manually, for each individual patient, which is very expensive. The innovative project is financed by the Berlin Institute of Health (BIH).
The complete press release and images can be found in the download area below. We are looking forward to a publication.
OPTIMA packaging group GmbH
+49 (0)791 / 506-1472
Editor: OPTIMA packaging group GmbH Managing Directors: Hans Bühler, Dr. Jürgen Kuske Commercial Register: Stuttgart: HRB 571090 VAT Id.no.: DE 145 209 170 Tax No. 84060/09756
Further material to download document: Press release OPTIMA pharma started a cooperation with Charité_Tages- und Wirtschaftspresse_Eng.docx